Caricord
World’s only umbilical cord blood bank that is both public and private while also holding rigorous fda licensure.
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
N/A | Acquisition | ||
| Total Funding | 000k | ||
Related Content
CariCord operates in the healthcare sector, specializing in the collection and storage of placental and umbilical cord stem cells. These stem cells are crucial for future medical treatments and have life-saving potential. The company serves expectant parents who wish to secure their family's future health by banking these valuable cells. CariCord operates in the niche market of stem cell banking, leveraging exclusive worldwide patents for the discovery and recovery of placental stem cells. The business model revolves around a one-time collection fee and ongoing storage fees, ensuring a steady revenue stream. By offering advanced technology and comprehensive banking options, CariCord aims to maximize the number of stem cells preserved, thereby increasing the probability of successful medical treatments.
Keywords: placental stem cells, umbilical cord, stem cell banking, medical treatments, life-saving, healthcare, patents, collection, storage, expectant parents.